Global Health Limited has informed the Exchange regarding 'Key Performance Indicators for FY 2024-25'.
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Health (Medanta) shared its FY25 KPIs showing steady growth across operations. Bed capacity expanded to 3,042 beds (from 2,823 in FY24) with operational beds rising to 2,440, and average occupancy improving to 62.1% from 61.6%. Patient volumes grew, with outpatient footfalls up to 29.37 lakh and inpatient admissions up to 1.74 lakh. Total healthcare services revenue rose to about Rs 28,973 million from Rs 26,054 million, while EBITDA grew roughly 9% to Rs 9,562 million, though EBITDA margin slipped slightly to 25.4% from 26.1%. The company strengthened its balance sheet with debt-to-equity falling to 0.10x and DSCR improving sharply to 8.36x, but return on equity declined to 15.3% from 17.9%.
The KPI update shows Medanta continuing to scale up capacity and patient volumes, which is positive for revenue growth. However, the slight margin compression and lower ROE suggest rising costs from newer hospitals are weighing on profitability, while the strong debt metrics indicate solid financial health. Shareholders should view this as a steady operational update rather than a major catalyst.